1 completed, 1 recruiting. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Eric Lenze: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lumateperone for Late-Life Depression Lumateperone, Placebo - Treatment Resistant Depression (TRD), Late Life Depression (LLD) | Phase 3 | Recruiting | Eric Lenze | 100 | 2026-09-01 | 2026-09-16 |
| Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults Memantine, Placebo - Depression | Phase 4 | Completed | Eric Lenze | 35 | 2005-08-01 | 2018-01-17 |
Depression (2) · Depressive Disorder, Major (2) · Depressive Disorder, Treatment-Resistant (1) · Lethargy (1)
Memantine (1) · lumateperone (1)
United States (2)
Eric J Lenze, MD (1) · Eric J. Lenze, MD (1)
K23MH064196 (1)